Osteoprotegerin (OPG) is a cytokine that regulates bone resorption by inhibiting
osteoclastogenesis, and OPG has been implicated in the process that causes vascular …

Background: Cardiovascular disease is the major cause of morbidity and mortality in chronic
kidney disease (CKD) and early biomarkers are required which can predict disease and …

Abstract Background/Aims: Cardiovascular disease (CVD) is increased in chronic kidney
disease (CKD), and contributed to by the CKD-mineral bone disorder (CKD-MBD). CKD …

Aims: To assess (a) plasma osteopontin (pOPN) in a cohort of chronic kidney disease (CKD)
patients;(b) the relationship between pOPN and aortic calcification and stiffness, and (c) the …

Abstract Introduction Vascular calcifications (VCs) and renal osteodystrophy (ROD) are
frequently seen together and represent the major causes of morbidity and mortality in …

The objective of this study was to evaluate the correlation of bone mineral density (BMD),
evaluated by DXA, with vascular calcifications, arterial stiffness, and vascular disease in …

Background: Cardiovascular mortality is extremely high in patients on hemodialysis. Among
a variety of pathophysiological conditions, deranged calcium homeostasis including …

Abstract Background/Aims: Both arterial stiffness and coronary artery calcification (CAC) are
important predictors of cardiovascular disease in the general population and in chronic …

Background: Vascular calcification is believed to have a crucial role in the excess
cardiovascular mortality and morbidity in patients with end-stage renal disease (ESRD) …

Backgrounds Osteocalcin (OC) is a known bone metabolic marker and a regulator of
glucose and fat metabolisms. Although bone and energy metabolisms are known risk factors …